Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 34893 - cannula, arterial - the optisite arterial cannula has a smoothly rounded tip to facilitate atraumatic insertion and a blunt tip introducer with guidewire. the proximal ends of the cannulae are designed to accept 3/8" (9.5mm) tubing. introducers are designed for use with 0.038? (0.96mm) guidewires. each introducer is provided with a removable vented luer cap. leave the vented cap in place to allow venting of the cannula for use without a guidewire. remove the cap to allow cannula use with a guidewire. the edwards lifesciences arterial perfusion cannulae are indicated for arterial perfusion in the extracorporeal circuit for < 6 hours. cannulation site selection is left to the discretion of the surgeon and may include the femoral artery or the aortic arch.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd - 47733 - cardiopulmonary bypass cannula, femoral - femoral access arterial cannula. wire-reinforced and thin-wall cannula with introducer that passes over a 0.038" (0.96 mm) guidewire. the clear proximal section is not reinforced to allow clamping and terminates in a barbed connector. the cannula includes two barium stripes on the tubing to aid in placement. it comes in 16, 18, and 20fr sizes for use in adults. edwards lifesciences femoral access cannulae are intended for use in situations which require rapid femoral venous and arterial access for short-term (? 6 hours) cardiopulmonary bypass. vessel access (venous or arterial) is left to the discretion of the physician. femoral access cannulae may be used in paediatric populations or adult populations based on flow rate requirements and individual patient anatomy.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd -

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

edwards lifesciences pty ltd -

Singapura - Inggris - HSA (Health Sciences Authority)

edwards lifesciences (asia) pte. ltd. - cardiovascular - the cosgrove-edwards annuloplasty system, model 4600, is intended for use in patients to correct annular dilatation, increase leaflet coaptation, reinforce annular suture lines, and prevent further dilatation of the annulus.